GSK’s Nucala receives positive CHMP opinion for treatment of chronic obstructive pulmonary disease: London, UK Monday, December 15, 2025, 16:00 Hrs [IST] GSK plc announced that ...

India has the second-highest incidence of chronic obstructive pulmonary disease (CoPD) in the world, after China. What you need to know about CoPD and the cost of treatment for the chronic lung ...

Background The sit-to-stand (STS) test can assess physical function in people with chronic obstructive pulmonary disease (COPD); however, there are multiple versions. No study has used current ...

Using coronary artery calcium scores alongside cardiovascular risk scores better identifies patients with chronic obstructive ...

A new survey reveals 82% of Delhi-NCR residents know someone suffering serious health issues attributed to long-term air ...

Lung diseases are a major global health concern. Many conditions begin silently with subtle signs. Early detection of symptoms like breathlessness, pe ...

Among seven new medicines recommended for approval by the EMA's human medicine advisory committee at its latest meeting is ...

Joni Villanueva General Hospital Medical Specialist Linuel Trinidad underscores the importance of proper medication, correct inhaler use, regular exercise, and quitting smoking to prevent COPD from ...

COPD, which includes chronic bronchitis and emphysema, is progressive, meaning it gets worse over time without treatment. People with COPD have difficulty breathing because of inflammation and damage ...

The UCR accepts referrals from GPs, Hampshire hospitals, ambulance services, families, and patients themselves. It helps ...

Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s ...

GSK’s depemokimab, a long-acting biologic that’s key in the British pharma’s growth plan, has won an endorsement from ...